logo
AAT Bioquest

Adenosine A2 receptor Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
8-Cyclopentyl-1,3-dipropylxanthineIC50656.0 [1]
8-Cyclopentyl-1,3-dipropylxanthineKi140.0 [1], 157.0 [2], 320.0 [3], 590.0 [4]
TheophyllineKi13800.0 [1], 14000.0 [2], 16600.0 [3]
1,3-DipropylxanthineKi2400.0 [1], 2700.0 [2], 7400.0 [3]
RolofyllineKi108.0 [1], 230.0 [2], 430.0 [3]
EnprofyllineKi90600.0 [1], 130000.0 [2]
3-MethylxanthineKi133000.0 [1], 240000.0 [2]
1,3-Dipropyl-8-phenylxanthineKi10.0 [1], 2100.0 [2]
Benzoic acid, 4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-Ki320.0 [1]
8-(3-Oxatricyclo[3.2.1.02,4]octan-6-yl)-1,3-dipropyl-7H-purine-2,6-dioneKi465.0 [1], 475.0 [2]
[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxy]acetic acidKi34.0 [1], 800.0 [2]
((S)-(-)-8-(3-Oxocyclopentyl)-1,3-dipropyl-7H-purine-2,6-dione)Ki1512.0 [1], 2700.0 [2]
1,3-Dipropyl-8-(4-hydroxyphenyl)xanthineKi48.0 [1], 50.0 [2]
1h-Purine-2,6-dione, 8-cyclohexyl-3,7-dihydro-1,3-dipropyl-Ki190.0 [1]
1,3,7-Trimethyl-8-cyclohexylxanthineKi0.19 [1], 190.0 [2]
(2S,3S,4R,5R)-5-(6-Amino-2-pent-1-ynylpurin-9-yl)-N-ethyl-3,4-dihydroxyoxolane-2-carboxamideKi12.6 [1], 19.5 [2]
(2S,3S,4R)-5-(6-Amino-2-oct-1-ynylpurin-9-yl)-N-ethyl-3,4-dihydroxyoxolane-2-carboxamideIC5013500.0 [1]
(2S,3S,4R)-5-(6-Amino-2-oct-1-ynylpurin-9-yl)-N-ethyl-3,4-dihydroxyoxolane-2-carboxamideKi159.0 [1]
CaffeineKi30000.0 [1]
5'-N-EthylcarboxamidoadenosineKi70.0 [1]
N6-CyclopentyladenosineKi2400.0 [1]
8-PhenyltheophyllineKi1900.0 [1]
8-(p-Sulfophenyl)theophyllineKi5500.0 [1]
8-CyclopentyltheophyllineKi140.0 [1]
(R)-N-(1-Methyl-2-phenylethyl)adenosineKi1700.0 [1]
1-MethylxanthineKi1900.0 [1]
5-(N,N-Hexamethylene)amilorideIC50270.0 [1]
1,3-Dipropyl-8-p-sulfophenylxanthineKi1900.0 [1]
Xanthine amine congenerKi49.0 [1]
DenbufyllineKi31500.0 [1]
2-Hexynyl-NECAKi5.7 [1]
1,3-Dipropyl-7-methylxanthineKi2800.0 [1]
2-OctynyladenosineKi39.9 [1]
(+)-(R)-((E)-3-(2-Phenylpyrazolo(1,5-a)pyridin-3-yl)acryloyl)-2-piperidineethanolIC50100000.0 [1]
8-(Dicyclopropylmethyl)-1,3-dipropylxanthineKi430.0 [1]
1-Methyl-3-propyl-7H-purine-2,6-dioneKi8000.0 [1]
I-AbopxKi700.0 [1]
2-(1-Hexynyl)adenosineKi8.1 [1]
1,3,7-Trimethyl-8-phenylxanthineKi14000.0 [1]
1-Isoamyl-3-isobutylxanthineKi6500.0 [1]
TrabodenosonKi4692.0 [1]
1-Methyl-8-phenyl-3,7-dihydro-purine-2,6-dioneKi860.0 [1]
1,3-DiethylxanthineKi3000.0 [1]
8-Phenyl-1-propyl-3,7-dihydro-purine-2,6-dioneKi20.0 [1]
7,8-DnipoKi330.0 [1]
Benzoic acid, 4-(2,3,6,7-tetrahydro-1,3-dimethyl-2,6-dioxo-1H-purin-8-yl)-Ki1500.0 [1]
(8R)-8-Ethyl-4-propyl-2-(3-tricyclo[3.3.1.03,7]nonanyl)-8,9-dihydro-7H-imidazo[2,1-f]purin-5-oneKi290.0 [1]
8-(2-Hydroxy-4-methoxy-phenyl)-1,3-dipropyl-3,7-dihydro-purine-2,6-dioneKi180.0 [1]
1,3-Diallyl-3,7-dihydro-purine-2,6-dioneKi5000.0 [1]
8-(4-Hydroxyphenyl)theophyllineKi130.0 [1]
8-(2,4-Dihydroxy-phenyl)-1,3-dipropyl-3,7-dihydro-purine-2,6-dioneKi820.0 [1]
(2R,3R,4S,5R)-2-(6-Amino-2-hept-1-ynylpurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diolKi20.8 [1]
1H-Purine-2,6-dione, 3,7-dihydro-8-(4-methoxyphenyl)-1,3-dipropyl-Ki2900.0 [1]
8-Cyclohexylmethyl-1,3-dipropyl-3,7-dihydro-purine-2,6-dioneKi2700.0 [1]
(2,5-Dioxopyrrolidin-1-yl) 2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetateKi40.0 [1]
3-Isobutyl-1-(3-methyl-butyl)-8-phenyl-3,7-dihydro-purine-2,6-dioneKi2300.0 [1]
1H-Purine-2,6-dione, 3,7-dihydro-1,3-bis(2-methylpropyl)-Ki1700.0 [1]
2-(4-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy)-N-p-tolylacetamideKi750.0 [1]
Xanthine, 8-[4-[(aminocarbonyl)methoxy]phenyl]-1,3-dipropyl-Ki47.0 [1]
1H-Purine-2,6-dione, 8-cyclopentyl-3,7-dihydro-7-methyl-1,3-dipropyl-Ki220.0 [1]
2-[4-[3-[2-(4-Azido-3-iodophenyl)ethyl]-2,6-dioxo-1-propyl-7H-purin-8-yl]phenoxy]acetic acidKi5400.0 [1]
4-[1-(3-Methylbutyl)-3-(2-methylpropyl)-2,6-dioxo-7H-purin-8-yl]benzenesulfonic acidKi520.0 [1]
1-Methyl-3-propyl-7-ethylxanthineKi21500.0 [1]
1H-Purine-2,6-dione, 3,7-dihydro-1-methyl-3,7-dipropyl-Ki43800.0 [1]
2-[4-[4-(7-(111C)Methoxynaphthalen-1-yl)piperazin-1-yl]butyl]-4-methyl-1,2,4-triazine-3,5-dioneKi10000.0 [1]
2-[4-[4-(3-Methoxyphenyl)piperazin-1-yl]butyl]-4-methyl-1,2,4-triazine-3,5-dioneKi10000.0 [1]
2-[4-(2,6-Dioxo-1,3-dipropyl-7H-purin-8-yl)-3-hydroxyphenoxy]acetic acidKi2000.0 [1]
(8S)-8-Ethyl-4-propyl-2-(3-tricyclo[3.3.1.03,7]nonanyl)-8,9-dihydro-7H-imidazo[2,1-f]purin-5-oneKi250.0 [1]
2-[4-(1,3-Dimethyl-2,6-dioxo-7H-purin-8-yl)phenoxy]-N-(4-methylphenyl)acetamideKi20.0 [1]
Benzamide, 4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-Ki54.0 [1]
1,3-Dipropyl-8-pyrazin-2-yl-3,7-dihydro-purine-2,6-dioneKi3600.0 [1]
8-Cyclopentylmethyl-1,3-dipropyl-3,7-dihydro-purine-2,6-dioneKi1900.0 [1]
2-[4-[3-[2-(4-Aminophenyl)ethyl]-2,6-dioxo-1-propyl-7H-purin-8-yl]phenoxy]acetic acidKi11500.0 [1]
2-[4-[3-[2-(4-Amino-3-iodophenyl)ethyl]-2,6-dioxo-1-propyl-7H-purin-8-yl]phenoxy]acetic acidKi5300.0 [1]
N-[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-cyclohexylmethyl]-acetamideKi20.0 [1]
7-Methyl-8-phenyl-1,3-dipropyl-3,7-dihydro-purine-2,6-dioneKi2400.0 [1]
1,3,7-Trimethyl-8-(p-sulfophenyl)xanthineKi57000.0 [1]
8-Phenyl-3-propyl-3,7-dihydro-purine-2,6-dioneKi11000.0 [1]
8-Cyclohexyl-3-propyl-3,7-dihydro-purine-2,6-dioneKi1100.0 [1]
4-(2,6-Dioxo-3-propyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-benzenesulfonic acidKi2700.0 [1]
1-Ethyl-3-propyl-3,7-dihydro-purine-2,6-dioneKi3900.0 [1]
[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl nitrateKi951.0 [1]
8-Cyclohexyl-1,3-dimethyl-3,9-dihydro-1h-purine-2,6-dioneKi150.0 [1]
Xanthine, 1,3-dipropyl-8-[4-[[(4-hydroxy)phenylamino]carbonyl]methoxyphenyl]-Ki62.0 [1]
Xanthine, 8-[4-(ethoxycarbonyl)methoxyphenyl]-1,3-dipropyl-Ki30.0 [1]
(2R,3R,4S,5R)-2-(6-Amino-2-pent-1-ynylpurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diolKi7.3 [1]
1-Methyl-3-propyl-7-[3-(dimethylamino)propyl]xanthineKi200000.0 [1]
1-(2-Oxo-propyl)-3-propyl-3,7-dihydro-purine-2,6-dioneKi200000.0 [1]
1-Methyl-3-propyl-7-(2-hydroxyethyl)xanthineKi200000.0 [1]
N-(2-Acetamidoethyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamideKi62.0 [1]
3-(2,6-Dioxo-3-propyl-2,3,6,7-tetrahydro-purin-1-yl)-propionitrileKi162000.0 [1]
3-(2,6-Dioxo-3-propyl-2,3,6,7-tetrahydro-purin-1-yl)-propionic acidKi200000.0 [1]
1-Methyl-3-propyl-7-(3-hydroxypropyl)xanthineKi200000.0 [1]
1H-Purine-2,6-dione, 3,7-dihydro-1-methyl-7-(2-propenyl)-3-propyl-Ki12100.0 [1]
(2,6-Dioxo-3-propyl-2,3,6,7-tetrahydro-purin-1-yl)-acetic acidKi200000.0 [1]
1-(2-Methoxy-ethyl)-3-propyl-3,7-dihydro-purine-2,6-dioneKi21600.0 [1]
(1-Methyl-2,6-dioxo-3-propyl-1,2,3,6-tetrahydro-purin-7-yl)-acetic acidKi200000.0 [1]
1-Methyl-3-propyl-7-[2-(dimethylamino)ethyl]xanthineKi200000.0 [1]
1-Methyl-3-propyl-7-(2-ethoxyethyl)xanthineKi22900.0 [1]
1-Allyl-3-propyl-3,7-dihydro-purine-2,6-dioneKi11800.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Adenosine A2 receptor Inhibitors (IC50, Ki)." AAT Bioquest, Inc.21 Nov2024https://www.aatbio.com/data-sets/adenosine-a2-receptor-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 21). Quest Database™ Adenosine A2 receptor Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/adenosine-a2-receptor-inhibitors-ic50-ki.
BibTeXEndNoteRefMan